Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation - PubMed (original) (raw)
Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation
W Pratipanawatr et al. Diabetes. 2001 Nov.
Abstract
Normoglycemic subjects with a strong family history of type 2 diabetes are insulin resistant, but the mechanism of insulin resistance in skeletal muscle of such individuals is unknown. The present study was undertaken to determine whether abnormalities in insulin-signaling events are present in normoglycemic, nonobese subjects with a strong family history of type 2 diabetes. Hyperinsulinemic-euglycemic clamps with percutaneous muscle biopsies were performed in eight normoglycemic relatives of type 2 diabetic patients (FH(+)) and eight control subjects who had no family history of diabetes (FH(-)), with each group matched for age, sex, body composition, and ethnicity. The FH(+) group had decreased insulin-stimulated glucose disposal (6.64 +/- 0.52 vs. 8.45 +/- 0.54 mg. kg(-1) fat-free mass. min(-1); P < 0.05 vs. FH(-)). In skeletal muscle, the FH(+) and FH(-) groups had equivalent insulin stimulation of insulin receptor tyrosine phosphorylation. In contrast, the FH(+) group had decreased insulin stimulation of insulin receptor substrate (IRS)-1 tyrosine phosphorylation (0.522 +/- 0.077 vs. 1.328 +/- 0.115 density units; P < 0.01) and association of PI 3-kinase activity with IRS-1 (0.299 +/- 0.053 vs. 0.466 +/- 0.098 activity units; P < 0.05). PI 3-kinase activity was correlated with the glucose disposal rate (r = 0.567, P = 0.02). In five subjects with sufficient biopsy material for further study, phosphorylation of Akt was 0.266 +/- 0.061 vs. 0.404 +/- 0.078 density units (P < 0.10) and glycogen synthase activity was 0.31 +/- 0.06 vs. 0.50 +/- 0.12 ng. min(-1). mg(-1) (P < 0.10) for FH(+) and FH(-) subjects, respectively. Therefore, despite normal insulin receptor phosphorylation, postreceptor signaling was reduced and was correlated with glucose disposal in muscle of individuals with a strong genetic background for type 2 diabetes.
Similar articles
- Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients.
Miyazaki Y, He H, Mandarino LJ, DeFronzo RA. Miyazaki Y, et al. Diabetes. 2003 Aug;52(8):1943-50. doi: 10.2337/diabetes.52.8.1943. Diabetes. 2003. PMID: 12882909 Clinical Trial. - Insulin signal transduction in skeletal muscle from glucose-intolerant relatives of type 2 diabetic patients [corrected].
Storgaard H, Song XM, Jensen CB, Madsbad S, Björnholm M, Vaag A, Zierath JR. Storgaard H, et al. Diabetes. 2001 Dec;50(12):2770-8. doi: 10.2337/diabetes.50.12.2770. Diabetes. 2001. PMID: 11723060 - Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes.
Storgaard H, Jensen CB, Björnholm M, Song XM, Madsbad S, Zierath JR, Vaag AA. Storgaard H, et al. J Clin Endocrinol Metab. 2004 Mar;89(3):1301-11. doi: 10.1210/jc.2003-031243. J Clin Endocrinol Metab. 2004. PMID: 15001626 Clinical Trial. - Alteration in insulin action: role of IRS-1 serine phosphorylation in the retroregulation of insulin signalling.
Tanti JF, Gual P, Grémeaux T, Gonzalez T, Barrès R, Le Marchand-Brustel Y. Tanti JF, et al. Ann Endocrinol (Paris). 2004 Feb;65(1):43-8. doi: 10.1016/s0003-4266(04)95629-6. Ann Endocrinol (Paris). 2004. PMID: 15122091 Review. - Insulin signaling and glucose transport in insulin resistant human skeletal muscle.
Karlsson HK, Zierath JR. Karlsson HK, et al. Cell Biochem Biophys. 2007;48(2-3):103-13. doi: 10.1007/s12013-007-0030-9. Cell Biochem Biophys. 2007. PMID: 17709880 Review.
Cited by
- The WCIRDC 2023: Concepts of insulin resistance.
Bloomgarden Z. Bloomgarden Z. J Diabetes. 2024 Mar;16(3):e13552. doi: 10.1111/1753-0407.13552. J Diabetes. 2024. PMID: 38516866 Free PMC article. No abstract available. - The Incidence and Management of Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus.
Ikoh Rph CL, Tang Tinong R. Ikoh Rph CL, et al. Cureus. 2023 Aug 31;15(8):e44468. doi: 10.7759/cureus.44468. eCollection 2023 Aug. Cureus. 2023. PMID: 37664380 Free PMC article. Review. - Insulin signalling and GLUT4 trafficking in insulin resistance.
van Gerwen J, Shun-Shion AS, Fazakerley DJ. van Gerwen J, et al. Biochem Soc Trans. 2023 Jun 28;51(3):1057-1069. doi: 10.1042/BST20221066. Biochem Soc Trans. 2023. PMID: 37248992 Free PMC article. Review. - Differential roles of insulin receptor in adipocyte progenitor cells in mice.
Yuan Y, Shi Z, Xiong S, Hu R, Song Q, Song Z, Ong SG, Jiang Y. Yuan Y, et al. Mol Cell Endocrinol. 2023 Aug 1;573:111968. doi: 10.1016/j.mce.2023.111968. Epub 2023 May 25. Mol Cell Endocrinol. 2023. PMID: 37244600 Free PMC article. - Can Circadian Eating Pattern Adjustments Reduce Risk or Prevent Development of T2D?
Harris C, Czaja K. Harris C, et al. Nutrients. 2023 Apr 4;15(7):1762. doi: 10.3390/nu15071762. Nutrients. 2023. PMID: 37049602 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous